Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
SHPH Shuttle Pharmaceuticals Holdings Inc
- Stocks
- Healthcare
- NASDAQ: SHPH
Price (delayed)
$4.245
Market cap
$1.87M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$64.75
Enterprise value
-$1.54M
Highlights
Shuttle Pharmaceuticals Holdings's EPS has increased by 31% YoY and by 19% from the previous quarter
Shuttle Pharmaceuticals Holdings's equity has increased by 19% YoY
The company's quick ratio has surged by 102% QoQ but it fell by 10% YoY
The net income has declined by 42% year-on-year and by 14% since the previous quarter
Key stats
What are the main financial stats of SHPH
Market
Valuations
Earnings
Shares outstanding
439,372
Market cap
$1.87M
Enterprise value
-$1.54M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.21
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$9.26M
Net income
-$10.47M
EBIT
-$9.74M
EBITDA
-$9.74M
Free cash flow
-$8.62M
Per share
Balance sheet
Liquidity
EPS
-$64.75
EPS diluted
-$67.5
Free cash flow per share
-$21.43
Book value per share
$20.15
Revenue per share
$0
TBVPS
$13.21
Total assets
$5.31M
Total liabilities
$2.02M
Debt
$1.1M
Equity
$3.29M
Working capital
$3.18M
Debt to equity
0.34
Current ratio
2.78
Quick ratio
2.53
Net debt/EBITDA
0.35
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-370.4%
Return on equity
-1,202.9%
Return on invested capital
-2,354.5%
Return on capital employed
-276.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SHPH stock price
How has the Shuttle Pharmaceuticals Holdings stock price performed over time
Intraday
2.04%
1 week
8.57%
1 month
-23.51%
1 year
-94.69%
YTD
-80.24%
QTD
12.75%
Financial performance
How have Shuttle Pharmaceuticals Holdings's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.26M
Net income
-$10.47M
Gross margin
N/A
Net margin
N/A
Shuttle Pharmaceuticals Holdings's operating income has shrunk by 62% YoY and by 20% QoQ
The net income has declined by 42% year-on-year and by 14% since the previous quarter
Price vs fundamentals
How does SHPH's price correlate with its fundamentals
Growth
What is Shuttle Pharmaceuticals Holdings's growth rate over time
Valuation
What is Shuttle Pharmaceuticals Holdings stock price valuation
P/E
N/A
P/B
0.21
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Shuttle Pharmaceuticals Holdings's EPS has increased by 31% YoY and by 19% from the previous quarter
Shuttle Pharmaceuticals Holdings's equity has increased by 19% YoY
Efficiency
How efficient is Shuttle Pharmaceuticals Holdings business performance
The ROA fell by 9% QoQ
SHPH's return on equity is up by 2.8% since the previous quarter
Dividends
What is SHPH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SHPH.
Financial health
How did Shuttle Pharmaceuticals Holdings financials performed over time
SHPH's total assets is 162% greater than its total liabilities
SHPH's total assets has soared by 112% since the previous quarter and by 12% year-on-year
The company's quick ratio has surged by 102% QoQ but it fell by 10% YoY
The debt is 66% lower than the equity
The company's debt to equity has shrunk by 79% QoQ and by 28% YoY
Shuttle Pharmaceuticals Holdings's equity has increased by 19% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.